Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study

Author:

Lopes Snehal S.ORCID,Pericot-Valverde IreneORCID,Arnsten Julia,Lum Paula J.,Taylor Lynn E.,Mehta Shruti H.ORCID,Tsui Judith I.,Feinberg JudithORCID,Kim Arthur Y.ORCID,Norton Brianna L.,Page Kimberly,Murray-Krezan CristinaORCID,Anderson JessicaORCID,Moschella Phillip,Heo MoonseongORCID,Litwin Alain H.ORCID

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference41 articles.

1. AASLD-IDSA. (10/24/2022). HCV Resistance Primer. Recommendations for testing, managing, and treating hepatitis C. Retrieved 10/5/2023 from https://www.hcvguidelines.org/evaluate/resistance.

2. The use of technology-based adherence monitoring in the treatment of hepatitis C virus;Adje;Therapeutic Advances in Infectious Disease,2022

3. A phylogenetic analysis of hepatitis C virus transmission, relapse, and reinfection among people who inject drugs receiving opioid agonist therapy;Akiyama;Journal of Infectious Diseases,2020

4. Treatment of hepatitis C virus infection among people who are actively injecting drugs: A systematic review and meta-analysis;Aspinall;Clinical Infectious Diseases,2013

5. Prevention and management of treatment failure to new oral hepatitis C drugs;Benítez-Gutiérrez;Expert Opinion on Pharmacotherapy,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3